Haldey, E J <br/><br/>
Cardiovascular events and COX-2 inhibitors.  [electronic resource] 

 -  JAMA  Dec 2001 
 - 2809-10; author reply 2811-2 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>0098-7484 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Inflammatory Agents, Non-Steroidal--adverse effects<br/>Cardiovascular Diseases--epidemiology<br/>Cyclooxygenase 2<br/>Cyclooxygenase 2 Inhibitors<br/>Cyclooxygenase Inhibitors--adverse effects<br/>Humans<br/>Isoenzymes--antagonists & inhibitors<br/>Meloxicam<br/>Membrane Proteins<br/>Prostaglandin-Endoperoxide Synthases<br/>Risk Factors<br/>Thiazines--adverse effects<br/>Thiazoles--adverse effects